Development of Selective CBP/P300 Benzoxazepine Bromodomain Inhibitors. Popp, T. A., Tallant, C., Rogers, C., Fedorov, O., Brennan, P. E., Mueller, S., Knapp, S., & Bracher, F. JOURNAL OF MEDICINAL CHEMISTRY, 59(19):8889-8912, OCT 13, 2016.
doi  bibtex   
@article{ WOS:000385607100015,
Author = {Popp, Tobias A. and Tallant, Cynthia and Rogers, Catherine and Fedorov,
   Oleg and Brennan, Paul E. and Mueller, Susanne and Knapp, Stefan and
   Bracher, Franz},
Title = {Development of Selective CBP/P300 Benzoxazepine Bromodomain Inhibitors},
Journal = {JOURNAL OF MEDICINAL CHEMISTRY},
Year = {2016},
Volume = {59},
Number = {19},
Pages = {8889-8912},
Month = {OCT 13},
DOI = {10.1021/acs.jmedchem.6b00774},
ISSN = {0022-2623},
EISSN = {1520-4804},
ResearcherID-Numbers = {Fedorov, Oleg/B-6412-2014
   Knapp, Stefan/AAG-2347-2019
   },
ORCID-Numbers = {Brennan, Paul/0000-0002-8950-7646
   Muller-Knapp, Susanne/0000-0003-2402-4157
   Knapp, Stefan/0000-0001-5995-6494
   Tallant, Cynthia/0000-0001-5645-435X},
Unique-ID = {WOS:000385607100015},
}

Downloads: 0